You are here

Article Text

Article menu
Download PDFPDF
Editorial commentary
Cognitive-behavioural therapy does meaningfully reduce depression in people with epilepsy
  1. Markus Reuber
  1. Correspondence to Professor Markus Reuber, Academic Unit of Neurology, University of Sheffield, Sheffield S10 2JF, UK; mreuber{at}doctors.org.uk

https://doi.org/10.1136/jnnp-2018-318743

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    “Why should we require better ‘number needed to treat’ statistics from psychological than from pharmacological treatments?”

    Reading the title of the study by Noble et al 1 in Journal of Neurology, Neurosurgery and Psychiatry, ‘Cognitive-behavioural therapy does not meaningfully reduce depression in most people with epilepsy: a systematic review with a reliable change analysis’, stakeholders in ‘Psychotherapy Incorporated’ may wonder whether they need to rush to their stockbroker and sell their cognitive-behavioural therapy (CBT) shares. They need not hurry—but they will need to read the whole paper or this comment.

    The pooled findings of the meta-analysis by Noble et al of five randomised controlled studies in which at least some elements of CBT were used to treat depression or anxiety in patients with epilepsy demonstrate that the chances of reliable improvement according …

    View Full Text

    Footnotes

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient consent Not required.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles